​Independence Drug Formulary updates

November 16, 2022

​Independence Blue Cross (Independence) and Independence Administrators will make changes to their Select Drug Program® Formulary and Value Formulary. The changes are effective January 1, 2023, and will include:

Changes in traditional glucose monitoring supplies

  • Effective January 1, 2023, OneTouch®​ produc​ts will no longer be the preferred brand test strip/meters on the Select Drug Program and on the Value Formulary.
    • On the Select Drug Program, OneTouch® and all non-Contour® test strips will be non-preferred and will require prior authorization.
    • On the Value Formulary, OneTouch® and all non-Contour® test strips will be non-formulary.
  • Contour® NEXT will be the preferred brand test strip/meters and will not require prior authorization.
  • With the changes in preferred test strips, Independence is offering a free Contour® Next One meter. The new meter can be used with the preferred brand Contour® test strips.

Changes in continuous glucose monitoring (CGM) supplies

  • Effective January 1, 2023, Freestyle Libre® products will no longer be the preferred CGM on the Select Drug Program and on the Value Formulary.
    • On the Select Drug Program, Freestyle Libre® will be non-preferred and will require prior authorization.
    • On the Value Formulary, Freestyle Libre® will be non-formulary.
  • Dexcom®​ products will be the preferred CGM.

Review the changes that go into effect January 1, 2023:

For more information on pharmacy policies and programs, visit the Independence Blue Cross and Independence Administrators websites.​